e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Respiratory structure and function
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of polymorphonuclear neutrophil leucocytes in the development of bronchial hyperreactivity in chronic obstructive pulmonary disease
V. Cukic, V. Lovre, S. Genjac, A. Ustamujic, J. Mornjakovic, J. Maglajlic, M. Zecevic-Masic (Sarajevo, Bosnia And Herzegovina)
Source:
Annual Congress 2008 - Respiratory structure and function
Session:
Respiratory structure and function
Session type:
Thematic Poster Session
Number:
967
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Cukic, V. Lovre, S. Genjac, A. Ustamujic, J. Mornjakovic, J. Maglajlic, M. Zecevic-Masic (Sarajevo, Bosnia And Herzegovina). The role of polymorphonuclear neutrophil leucocytes in the development of bronchial hyperreactivity in chronic obstructive pulmonary disease. Eur Respir J 2008; 32: Suppl. 52, 967
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Airway epithelium, lymphocyte, neutrophil and macrophage apoptosis in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 640-646
Year: 2005
Airway neutrophilia in COPD is not associated with increased neutrophil survival
Source: Eur Respir J 2006; 28: 1163-1169
Year: 2006
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 612-617
Year: 2005
Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001
Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Polymorphonuclear elastasa and collagenasa activity in patients with chronic obstructive pulmonary disease and acute bronchities
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001
Role of neutrophils in airway inflammation in patients with pneumoconiosis and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 322s
Year: 2004
Peripheral lung remodelling in asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 893-894
Year: 2004
Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Increased CD4+ T-cell infiltration in bronchial epithelium of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007
Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD
Source: Eur Respir J 2012; 40: 1098-1105
Year: 2012
Role of neutrophils in airway inflammation in children with chronic bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 17s
Year: 2002
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
The role of small airways in obstructive airway diseases
Source: Eur Respir Rev 2011; 20: 23-33
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept